Literature DB >> 19012987

Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures.

Carlijn I Buis1, Erwin Geuken, Dorien S Visser, Folkert Kuipers, Elizabeth B Haagsma, Henkjan J Verkade, Robert J Porte.   

Abstract

BACKGROUND/AIMS: Nonanastomotic biliary strictures are troublesome complications after liver transplantation. The pathogenesis of NAS is not completely clear, but experimental studies suggest that bile salt toxicity is involved.
METHODS: In one hundred and eleven adult liver transplants, bile samples were collected daily posttransplantation for determination of bile composition. Expression of bile transporters was studied perioperatively.
RESULTS: Nonanastomotic biliary strictures were detected in 14 patients (13%) within one year after transplantation. Patient and donor characteristics and postoperative serum liver enzymes were similar between patients who developed nonanastomotic biliary strictures and those who did not. Secretions of bile salts, phospholipids and cholesterol were significantly lower in patients who developed strictures. In parallel, biliary phospholipids/bile salt ratio was lower in patients developing strictures, suggestive for increased bile cytotoxicity. There were no differences in bile salt pool composition or in hepatobiliary transporter expression.
CONCLUSIONS: Although patients who develop nonanastomotic biliary strictures are initially clinically indiscernible from patients who do not develop nonanastomotic biliary strictures, the biliary bile salts and phospholipids secretion, as well as biliary phospholipids/bile salt ratio in the first week after transplantation, was significantly lower in the former group. This supports the concept that bile cytotoxicity is involved in the pathogenesis of nonanastomotic biliary strictures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012987     DOI: 10.1016/j.jhep.2008.07.032

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

1.  Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.

Authors:  Annika Gauss; Robert Ehehalt; Wolf-Dieter Lehmann; Gerhard Erben; Karl-Heinz Weiss; Yvonne Schaefer; Petra Kloeters-Plachky; Adolf Stiehl; Wolfgang Stremmel; Peter Sauer; Daniel Nils Gotthardt
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation.

Authors:  B G Bruinsma; H Yeh; S Ozer; P N Martins; A Farmer; W Wu; N Saeidi; S Op den Dries; T A Berendsen; R N Smith; J F Markmann; R J Porte; M L Yarmush; K Uygun; M-L Izamis
Journal:  Am J Transplant       Date:  2014-04-23       Impact factor: 8.086

3.  Establishment of a rat liver transplantation model with prolonged biliary warm ischemia time.

Authors:  Xin-Hua Zhu; Jun-Ping Pan; Ya-Fu Wu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Altered alkaline phosphatase activity in obese Zucker rats liver respect to lean Zucker and Wistar rats discussed in terms of all putative roles ascribed to the enzyme.

Authors:  V Bertone; E Tarantola; A Ferrigno; E Gringeri; S Barni; M Vairetti; I Freitas
Journal:  Eur J Histochem       Date:  2011-02-08       Impact factor: 3.188

5.  Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation.

Authors:  Raffaele Cursio; Jean Gugenheim
Journal:  J Transplant       Date:  2012-02-29

6.  Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion.

Authors:  Michael E Sutton; Sanna op den Dries; Negin Karimian; Pepijn D Weeder; Marieke T de Boer; Janneke Wiersema-Buist; Annette S H Gouw; Henri G D Leuvenink; Ton Lisman; Robert J Porte
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Liver Preservation by Aortic Perfusion Alone Compared With Preservation by Aortic Perfusion and Additional Arterial Ex Situ Back-Table Perfusion With Histidine-Tryptophan-Ketoglutarate Solution: A Prospective, Randomized, Controlled, Multicenter Study.

Authors:  Gerd Otto; Michael Heise; Jochen Thies; Michael Pitton; Jens Schneider; Gernot Kaiser; Peter Neuhaus; Otto Kollmar; Michael Barthels; Josef Geks; Wolf Otto Bechstein; Achim Hellinger; Jürgen Klempnauer; Winfried Padberg; Nils Frühauf; Andre Ebbing; Dietmar Mauer; Astrid Schneider; Robert Kwiecien; Kai Kronfeld
Journal:  Transplant Direct       Date:  2017-06-26

8.  Liver preservation with machine perfusion and a newly developed cell-free oxygen carrier solution under subnormothermic conditions.

Authors:  P Fontes; R Lopez; A van der Plaats; Y Vodovotz; M Minervini; V Scott; K Soltys; S Shiva; S Paranjpe; D Sadowsky; D Barclay; R Zamora; D Stolz; A Demetris; G Michalopoulos; J W Marsh
Journal:  Am J Transplant       Date:  2015-02       Impact factor: 8.086

9.  Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model.

Authors:  Jawaher Abdullah Alamoudi; Wenkuan Li; Nagsen Gautam; Marco Olivera; Jane Meza; Sandeep Mukherjee; Yazen Alnouti
Journal:  World J Hepatol       Date:  2021-05-27

10.  Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats.

Authors:  E Tarantola; V Bertone; G Milanesi; E Capelli; A Ferrigno; D Neri; M Vairetti; S Barni; I Freitas
Journal:  Eur J Histochem       Date:  2012-10-08       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.